REDUCING PANCREATIC CYST SURVEILLANCE: DEVELOPMENT OF THE DUTCH AMERICAN RISK STRATIFICATION TOOL (DART-I) TO IDENTIFY IPMN WITH LOW RISK TO PROGRESS AND FULFILL RESECTION CRITERIA

(1) Erasmus University Medical Center,Rotterdam,Netherlands

(2) New York University - Langone Medical Center,New York,United States

(3) Mayo Clinic Florida,Jacksonville, FL,United States

(4) Columbia University Medical Center,New York,United States



This item was part of UEG Week 2018

This item can be cited as: United European Gastroenterology Journal 2018; 6 (Supplement 1)